Evidence map›Paper›PMID 24477263›Full record

ReviewInternational journal of molecular sciences2014

Adenosine receptors: expression, function and regulation.

Sandeep Sheth, Rafael Brito, Debashree Mukherjea, Leonard P Rybak, Vickram Ramkumar

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 211 papers.

0numbers the graph read from it
0cells of the map it votes in
211citing papers in PubMed
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

211 citing papers in PubMed, 383 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Applying Deep-Learning-DrivenJournal of medicinal chemistry · 2026
    Article
  7. Review
  8. Review
  9. Discovery of Potent 1,3-Cyclobutane-Containing Dual AACS medicinal chemistry letters · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Inhibition of Retinal AdoRA2a Activity Attenuates Myopia Progression.Investigative ophthalmology & visual science · 2026
    Article
  19. Review
  20. Article

151 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Sandeep ShethDepartment of Pharmacology and Neuroscience, Southern Illinois University School of Medicine, Springfield, IL 62702, USA. ssheth@siumed.edu.
Rafael BritoDepartment of Pharmacology and Neuroscience, Southern Illinois University School of Medicine, Springfield, IL 62702, USA. rafaelbs2002@yahoo.com.br.
Debashree MukherjeaDepartment of Surgery (Otolaryngology), Southern Illinois University School of Medicine, Springfield, IL 62702, USA. dmukherjea@siumed.edu.
Leonard P RybakDepartment of Pharmacology and Neuroscience, Southern Illinois University School of Medicine, Springfield, IL 62702, USA. lrybak@siumed.edu.
Vickram RamkumarDepartment of Pharmacology and Neuroscience, Southern Illinois University School of Medicine, Springfield, IL 62702, USA. vramkumar@siumed.edu.
Southern Illinois University School of Medicine · USUniversidade Federal Fluminense · BR

Funding

ENDOGENOUS MODULATION OF OTOTOXICITY OF CISPLATINR01DC002396 · NIDCD · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI RYBAK, LEONARD P · 1994 to 2018
$4.7M
Transplatin: A Novel Agent to Mitigate Cisplatin ToxicityR01CA166907 · NCI · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI RAMKUMAR, VICKRAM · 2013 to 2017
$1.5M
Targeting Inflammation for the Amelioration of Cisplatin-Hearing LossR15DC011412 · NIDCD · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI RAMKUMAR, VICKRAM · 2011 to 2011
$437k
Novel Approaches for Prevention and Treatment of Noise Induced Hearing lossR03DC011621 · NIDCD · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI MUKHERJEA, DEBASHREE · 2012 to 2014
$429k
Role of adenosine A3 receptor in suppressing prostate cancerR15CA135494 · NCI · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI RAMKUMAR, VICKRAM · 2008 to 2008
$218k
NCI NIH HHS R01 CA166907NCI NIH HHS R01-CA166907NCI NIH HHS R15 CA135494NIDCD NIH HHS R01 DC002396NIDCD NIH HHS R01-DC002396NIDCD NIH HHS R03 DC011621NIDCD NIH HHS R15 DC011412NIDCD NIH HHS R15DC011412
6 · The paper itself

Abstract

Adenosine receptors (ARs) comprise a group of G protein-coupled receptors (GPCR) which mediate the physiological actions of adenosine. To date, four AR subtypes have been cloned and identified in different tissues. These receptors have distinct localization, signal transduction pathways and different means of regulation upon exposure to agonists. This review will describe the biochemical characteristics and signaling cascade associated with each receptor and provide insight into how these receptors are regulated in response to agonists. A key property of some of these receptors is their ability to serve as sensors of cellular oxidative stress, which is transmitted by transcription factors, such as nuclear factor (NF)-κB, to regulate the expression of ARs. Recent observations of oligomerization of these receptors into homo- and heterodimers will be discussed. In addition, the importance of these receptors in the regulation of normal and pathological processes such as sleep, the development of cancers and in protection against hearing loss will be examined.

Indexed as

AnimalsGene Expression RegulationHearing LossHumansNeoplasmsNF-kappa BPhosphorylationProtein MultimerizationPurinergic P1 Receptor AgonistsReceptors, Purinergic P1Signal TransductionSleepNF-kappa BPurinergic P1 Receptor AgonistsReceptors, Purinergic P1

Identifiers

PMID24477263
PMCPMC3958836
OpenAlexW2095596429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.